340 related articles for article (PubMed ID: 25434496)
21. Genetic predisposition to prostate cancer.
Benafif S; Eeles R
Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
[TBL] [Abstract][Full Text] [Related]
22. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
23. Association of six susceptibility Loci with prostate cancer in northern chinese men.
Zhang YR; Xu Y; Yang K; Liu M; Wei D; Zhang YG; Shi XH; Wang JY; Yang F; Wang X; Liang SY; Zhao CX; Wang F; Chen X; Sun L; Zhu XQ; Zhu L; Yang YG; Tang L; Jiao HY; Huo ZH; Yang Z
Asian Pac J Cancer Prev; 2012; 13(12):6273-6. PubMed ID: 23464444
[TBL] [Abstract][Full Text] [Related]
24. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
[TBL] [Abstract][Full Text] [Related]
25. Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.
Gilbert R; Martin RM; Evans DM; Tilling K; Davey Smith G; Kemp JP; Lane JA; Hamdy FC; Neal DE; Donovan JL; Metcalfe C
PLoS One; 2015; 10(10):e0136735. PubMed ID: 26431041
[TBL] [Abstract][Full Text] [Related]
26. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
[TBL] [Abstract][Full Text] [Related]
28. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
[TBL] [Abstract][Full Text] [Related]
29. Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
Srinivasan S; Stephens C; Wilson E; Panchadsaram J; DeVoss K; Koistinen H; Stenman UH; Brook MN; Buckle AM; Klein RJ; Lilja H; Clements J; Batra J;
Clin Chem; 2019 Jan; 65(1):e1-e9. PubMed ID: 30538125
[TBL] [Abstract][Full Text] [Related]
30. Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.
Cornu JN; Cancel-Tassin G; Cox DG; Roupret M; Koutlidis N; Bigot P; Valeri A; Ondet V; Gaffory C; Fournier G; Azzouzi AR; Cormier L; Cussenot O
Eur Urol; 2016 Jul; 70(1):6-8. PubMed ID: 26850968
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
Jin G; Zheng SL; Lilja H; Kim ST; Tao S; Gao Z; Young T; Wiklund F; Feng J; Isaacs WB; Rittmaster RS; Gronberg H; Condreay LD; Sun J; Xu J
Neoplasia; 2013 Jan; 15(1):95-101. PubMed ID: 23359319
[TBL] [Abstract][Full Text] [Related]
32. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.
Pomerantz MM; Werner L; Xie W; Regan MM; Lee GS; Sun T; Evan C; Petrozziello G; Nakabayashi M; Oh WK; Kantoff PW; Freedman ML
Cancer Prev Res (Phila); 2011 May; 4(5):719-28. PubMed ID: 21367958
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.
Na R; Liu F; Zhang P; Ye D; Xu C; Shao Q; Qi J; Wang X; Chen Z; Wang M; He D; Wang Z; Zhou F; Yuan J; Gao X; Wei Q; Yang J; Jiao Y; Ou-Yang J; Zhu Y; Wu Q; Chen H; Lu D; Shi R; Lin X; Jiang H; Wang Z; Jiang D; Sun J; Zheng SL; Ding Q; Mo Z; Sun Y; Xu J
Prostate; 2013 Nov; 73(15):1623-35. PubMed ID: 24038036
[TBL] [Abstract][Full Text] [Related]
34. 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort.
Chan JY; Li H; Singh O; Mahajan A; Ramasamy S; Subramaniyan K; Kanesvaran R; Sim HG; Chong TW; Teo YY; Chia SE; Tan MH; Chowbay B
Urol Oncol; 2013 Nov; 31(8):1553-60. PubMed ID: 22561070
[TBL] [Abstract][Full Text] [Related]
35. Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men.
Zheng SL; Hsing AW; Sun J; Chu LW; Yu K; Li G; Gao Z; Kim ST; Isaacs WB; Shen MC; Gao YT; Hoover RN; Xu J
Prostate; 2010 Mar; 70(4):425-32. PubMed ID: 19866473
[TBL] [Abstract][Full Text] [Related]
36. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jin G; Lu L; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Cannon-Albright LA; Camp NJ; Teerlink CC; Fitzgerald LM; Stanford JL; Wiley KE; Isaacs SD; Walsh PC; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Thibodeau SN; McDonnell SK; Schaid DJ; Wiklund F; Grönberg H; Emanuelsson M; Whittemore AS; Oakley-Girvan I; Hsieh CL; Wahlfors T; Tammela T; Schleutker J; Catalona WJ; Zheng SL; Ostrander EA; Isaacs WB; Xu J;
Hum Genet; 2012 Jul; 131(7):1095-103. PubMed ID: 22198737
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants in RNA-induced silencing complex genes and prostate cancer.
Nikolić Z; Savić Pavićević D; Vučić N; Cerović S; Vukotić V; Brajušković G
World J Urol; 2017 Apr; 35(4):613-624. PubMed ID: 27498138
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
[TBL] [Abstract][Full Text] [Related]
39. Evaluating genetic risk for prostate cancer among Japanese and Latinos.
Cheng I; Chen GK; Nakagawa H; He J; Wan P; Laurie CC; Shen J; Sheng X; Pooler LC; Crenshaw AT; Mirel DB; Takahashi A; Kubo M; Nakamura Y; Al Olama AA; Benlloch S; Donovan JL; Guy M; Hamdy FC; Kote-Jarai Z; Neal DE; Wilkens LR; Monroe KR; Stram DO; Muir K; Eeles RA; Easton DF; Kolonel LN; Henderson BE; Le Marchand L; Haiman CA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2048-58. PubMed ID: 22923026
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide association study of serum albumin:globulin ratio in Korean populations.
Hong KW; Jin HS; Song D; Kwak HK; Kim SS; Kim Y
J Hum Genet; 2013 Mar; 58(3):174-7. PubMed ID: 23303382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]